Back to RA Capital Management, L.P. RA Capital Management, L.P.

TXGTXG

4 quarters

Position history for RA Capital Management, L.P.RA Capital Management, L.P.'s holdings in 10x Genomics, Inc.

No. RA Capital Management exited its TXG (10x Genomics) position in Q3 2025. Its Q2 2025 13F listed 475,343 shares worth $5.5M. RA Capital Management first reported TXG in Q4 2024 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$47.1M

Total Shares Change

-3.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$11.34
0
2025-Q2
Decreased
475,343
-75.5%
$5.5M0.1%$11.73
0
2025-Q1
Decreased
1.9M
-40.7%
$17M0.3%$9.16
0
2024-Q4
New
3.3M
—
$47.1M0.6%$14.35
57

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used